US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DoubleLine Multi-Sector Income ETF

49.63

-0.0400-0.08%

Volume:13.85K

Turnover:686.88K

Market Cap:107.19M

PE:- -

High:49.64

Open:49.57

Low:49.57

Close:49.67

52wk High:50.83

52wk Low:49.55

Shares:2.16M

Float Shares:2.16M

Volume Ratio:1.85

T/O Rate:0.64%

Dividend:2.92

Dividend Rate:5.88%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

EVEREST MED Secures Exclusive Asian Rights to Promising FSGS Treatment Candidate DMX-200

Everest Medicines Takes Exclusive Asia Rights to Dimerix Kidney Drug DMX-200

EVEREST MED Secures Exclusive Rights for DMX-200 Development and Commercialization in Key Asian Markets

Dimerix Highlights ACTION3 Trial De-Risking and Commercial Potential for DMX-200

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/DMX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMX\",,,,,undefined,":{"symbol":"DMX","market":"US","secType":"STK","nameCN":"DoubleLine Multi-Sector Income ETF","latestPrice":49.625,"timestamp":1789408788851,"preClose":49.665,"halted":0,"volume":13850,"delay":0,"changeRate":-0.0008053961542333464,"floatShares":2160001,"shares":2160001,"eps":0,"marketStatus":"Trading","change":-0.04,"latestTime":"09-14 14:29:36 EDT","open":49.57,"high":49.6399,"low":49.565,"amount":686881.5674500001,"amplitude":0.001508,"askPrice":49.71,"askSize":100,"bidPrice":49.54,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":49.665,"sharesOutstanding":1540001,"nav":49.8784,"aum":97761728.08,"dividendRate":0.058847,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":49.665,"preClose":49.665,"latestTime":"16:15 EDT","volume":7,"amount":347.655,"timestamp":1789157700325,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.845909},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMX\",,,,,undefined,":{"symbol":"DMX","floatShares":2160001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.845909,"shares":2160001,"dividePrice":2.9203,"high":49.6399,"amplitude":0.001508,"preClose":49.665,"low":49.565,"week52Low":49.55,"pbRate":"--","week52High":50.83,"institutionHeld":0,"latestPrice":49.625,"eps":0,"divideRate":0.058847,"volume":13850,"delay":0,"ttmEps":0,"open":49.57,"prevYearClose":50.52,"prevWeekClose":49.665,"prevMonthClose":50.12,"prevQuarterClose":50.2404,"fiveDayClose":49.84,"twentyDayClose":50.09,"sixtyDayClose":50.135},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMX\",params:#limit:5,,,undefined,":[{"date":"2026-09-01","symbol":"DMX","amount":0.255907,"announcedDate":"2026-08-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-01","defaultRemindTime":1788269400000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-08","payableDate":"2026-09-01","currency":"USD","dateTimestamp":1788235200000,"payDate":"2026-09-08"},{"date":"2026-08-03","symbol":"DMX","amount":0.237301,"announcedDate":"2026-07-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-03","defaultRemindTime":1785763800000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-07","payableDate":"2026-08-03","currency":"USD","dateTimestamp":1785729600000,"payDate":"2026-08-07"},{"date":"2026-07-01","symbol":"DMX","amount":0.242868,"announcedDate":"2026-06-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-08","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-08"},{"date":"2026-06-01","symbol":"DMX","amount":0.234233,"announcedDate":"2026-05-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-01","defaultRemindTime":1780320600000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-05","payableDate":"2026-06-01","currency":"USD","dateTimestamp":1780286400000,"payDate":"2026-06-05"},{"date":"2026-05-01","symbol":"DMX","amount":0.241702,"announcedDate":"2026-04-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-01","defaultRemindTime":1777642200000,"name":"DoubleLine Multi-Sector Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-07","payableDate":"2026-05-01","currency":"USD","dateTimestamp":1777608000000,"payDate":"2026-05-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMX\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.209071,"currency":"USD"},{"executeDate":"2025-02-03","recordDate":"2025-02-03","paymentDate":"2025-02-07","value":0.268541,"currency":"USD"},{"executeDate":"2025-03-03","recordDate":"2025-03-03","paymentDate":"2025-03-07","value":0.255266,"currency":"USD"},{"executeDate":"2025-04-01","recordDate":"2025-04-01","paymentDate":"2025-04-07","value":0.28018,"currency":"USD"},{"executeDate":"2025-05-01","recordDate":"2025-05-01","paymentDate":"2025-05-07","value":0.19133,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1126052833","title":"EVEREST MED Secures Exclusive Asian Rights to Promising FSGS Treatment Candidate DMX-200","url":"https://stock-news.laohu8.com/highlight/detail?id=1126052833","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126052833?lang=en_us&edition=fundamental","pubTime":"2026-06-16 11:19","pubTimestamp":1781579940,"startTime":"0","endTime":"0","summary":"The Chinese innovative pharmaceutical industry is currently transitioning from scale expansion to a new phase of high-quality competition centered on clinical value and supported by full industrial...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","FSGS","DMX","BK1583","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643810157","title":"Everest Medicines Takes Exclusive Asia Rights to Dimerix Kidney Drug DMX-200","url":"https://stock-news.laohu8.com/highlight/detail?id=2643810157","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643810157?lang=en_us&edition=fundamental","pubTime":"2026-06-16 07:11","pubTimestamp":1781565109,"startTime":"0","endTime":"0","summary":"Everest Medicines Ltd. ( ($HK:1952) ) has provided an announcement. Everest Medicines has secured an exclusive license from Australia’s Dimerix Lim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/everest-medicines-takes-exclusive-asia-rights-to-dimerix-kidney-drug-dmx-200?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/everest-medicines-takes-exclusive-asia-rights-to-dimerix-kidney-drug-dmx-200?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","DMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146670548","title":"EVEREST MED Secures Exclusive Rights for DMX-200 Development and Commercialization in Key Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1146670548","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146670548?lang=en_us&edition=fundamental","pubTime":"2026-06-16 07:02","pubTimestamp":1781564543,"startTime":"0","endTime":"0","summary":"EVEREST MED (ASX: 01952) has announced the signing of an agreement with Dimerix Limited, a company listed on the Australian Securities Exchange under the ticker DXB.Under the terms of the deal,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","DMX","BK1583","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630344446","title":"Dimerix Highlights ACTION3 Trial De-Risking and Commercial Potential for DMX-200","url":"https://stock-news.laohu8.com/highlight/detail?id=2630344446","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630344446?lang=en_us&edition=fundamental","pubTime":"2026-04-28 08:36","pubTimestamp":1777336575,"startTime":"0","endTime":"0","summary":"Dimerix Limited ( ($AU:DXB) ) just unveiled an announcement. Dimerix Limited has released an updated investor presentation and video detailing prog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dimerix-highlights-action3-trial-de-risking-and-commercial-potential-for-dmx-200?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dimerix-highlights-action3-trial-de-risking-and-commercial-potential-for-dmx-200?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DMX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":44,"code":"91000000","status":"200"}]}}